Industry needs no more control, says Zydus COO

Updated - November 16, 2021 08:45 pm IST

Published - June 07, 2013 12:34 am IST

Ganesh Nayak

Ganesh Nayak

Pharma major Zydus Cadila believes that despite the recent Ranbaxy episode involving adulterated generic drugs, the pharma industry does not need more domestic and international regulation.

According to Chief Operating Officer Ganesh Nayak, it is also “wholly unfair” to judge the whole Indian generic industry based on one episode or instance.

The Ahmedabad-based company recently launched its Liapglyn drug, which is aimed at treating Type II diabetes.

“Let’s make something clear. The industry, as a whole, is subjected to many, many inspections every month. Nothing more is required. I don’t believe that the industry needs further regulation by any domestic or international agency,” Mr. Nayak told The Hindu in an interview on Thursday. “If one person in a group is a criminal, how can you judge all of them to be criminals? I don’t think it is fair to say the generic pharma image has also taken a beating, none of our clients in U.S or Japan are asking us what is wrong,” he added.

Medical management

Pointing out that a number of multinational firms were slapped with fines similar to that paid by Ranbaxy, Mr. Nayak said that a culture of medical management was important.

“Our company was founded by a pharmacist. In Zydus, most of our top management either have medical degrees or a history of working in medicine. In a way, this makes sure that we avoid doing anything inappropriate. While I don’t want to comment on Ranbaxy , even innovator pharma firms have faced fines in the past.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.